We would welcome proposals focused on the following:
Novel interventions for severe inflammatory bowel disease (IBD), including ulcerative colitis. Approaches for the treatment of non-alcoholic steatohepatitis (NASH), acute kidney injury (AKI), hepatic renal syndrome (HRS), and the complications of cirrhosis and iron overload conditions.
Identification of targets with utility in the prevention and/or treatment of preterm labor or preeclampsia. New modalities for the treatment of endometriosis, uterine fibroids, polycystic ovarian syndrome and non-hormonal treatments of menopausal symptoms. Improving fertility by targeting the molecular basis of embryo implantation, oocyte and embryo quality, FSH non-responders, anovulatory disorders, ovarian aging, and male factor infertility.
Innovative ideas for the treatment of disorders such as painful bladder syndrome/interstitial cystitis. Novel approaches to treat non-muscle invasive bladder cancer and prostate related disorders, with specific interest in the causes of progression to castration resistant and hormone sensitive prostate cancer. Identification of targets with utility in benign prostatic hyperplasia and refractory overactive bladder syndrome.
Identification and validation of biomarkers for use in any of the above listed disease indications.
View complete Ferring Innovation Grants Program Summary